- Home
- ICL vs LNTH Comparison
ICL vs LNTH Comparison
Compare ICL & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICL
- LNTH
- Stock Information
- Founded
- ICL 1968
- LNTH 1956
- Country
- ICL Israel
- LNTH United States
- Employees
- ICL N/A
- LNTH N/A
- Industry
- ICL Agricultural Chemicals
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ICL Industrials
- LNTH Health Care
- Exchange
- ICL Nasdaq
- LNTH Nasdaq
- Market Cap
- ICL 6.0B
- LNTH 6.3B
- IPO Year
- ICL N/A
- LNTH 2015
- Fundamental
- Price
- ICL $4.89
- LNTH $89.29
- Analyst Decision
- ICL Sell
- LNTH Strong Buy
- Analyst Count
- ICL 1
- LNTH 6
- Target Price
- ICL $4.00
- LNTH $132.67
- AVG Volume (30 Days)
- ICL 904.1K
- LNTH 1.0M
- Earning Date
- ICL 11-11-2024
- LNTH 11-06-2024
- Dividend Yield
- ICL 4.33%
- LNTH N/A
- EPS Growth
- ICL N/A
- LNTH 304.57
- EPS
- ICL 0.31
- LNTH 6.02
- Revenue
- ICL $6,930,000,000.00
- LNTH $1,496,799,000.00
- Revenue This Year
- ICL N/A
- LNTH $19.64
- Revenue Next Year
- ICL $4.82
- LNTH $4.38
- P/E Ratio
- ICL $15.78
- LNTH $14.83
- Revenue Growth
- ICL N/A
- LNTH 24.15
- 52 Week Low
- ICL $3.79
- LNTH $50.20
- 52 Week High
- ICL $5.54
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- ICL 53.14
- LNTH 44.02
- Support Level
- ICL $4.97
- LNTH $91.20
- Resistance Level
- ICL $5.16
- LNTH $96.46
- Average True Range (ATR)
- ICL 0.11
- LNTH 2.89
- MACD
- ICL -0.04
- LNTH 0.54
- Stochastic Oscillator
- ICL 13.86
- LNTH 26.33
About ICL ICL Group Ltd.
ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. The company mines and manufactures potash and phosphates to be used as ingredients in fertilizers and serve as a component in the pharmaceutical and food additives industries. It is also engaged in industrial additives and materials, including flame retardants, phosphate salts, specialty phosphate blends, purified phosphoric acid, electronic-grade specialty phosphoric acids. Its geographical segments are Europe, Asia, North and South America, and the Rest of the world.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.